Kimimichi Obata

No más puestos en curso

74 años

Health Technology

Perfil

Kimimichi Obata worked as a Director at Precision System Science Co., Ltd.
from 2011 to 2014.
He was also the President & Representative Director at Precision System Science USA, Inc. from 2001 to 2014.
Additionally, he served as a Director at Universal Bio Research Co., Ltd.
from 2002 to 2014.

Antiguos cargos conocidos de Kimimichi Obata.

Empresas	Cargo	Fin
PRECISION SYSTEM SCIENCE CO., LTD.	Director/Miembro de la Junta	16/11/2014
Universal Bio Research Co., Ltd.	Director/Miembro de la Junta	16/11/2014
Precision System Science USA, Inc. Precision System Science USA, Inc. Medical SpecialtiesHealth Technology Part of Precision System Science Co., Ltd., Precision System Science USA, Inc. is a company that provides user-friendly technology for DNA extraction. The company is based in Pleasanton, CA. The company offers MagDEA® Dx LV Prefilled reagents cartridges for consistent and uniform magnetic bead-based nucleic acid extractions for large, 1 to 5 mL, sample volumes. Akihiro Furukawa has been the CEO of the company since 2017.	Presidente	16/11/2014

Ver el detalle de la experiencia de Kimimichi Obata.

Experiencias
Funciones ocupadas

Activas

Inactivas

Empresas cotizadas

Empresas privadas

Ver el detalle de la experiencia de Kimimichi Obata.

Relaciones

Relaciones de 1er grado

Empresas vinculadas al 1er grado

Hombre

Mujer

Administradores

Ejecutivos

Consultar la red personal

Empresas relacionadas

Empresas cotizadas	1
PRECISION SYSTEM SCIENCE CO., LTD.	Health Technology

Empresas privadas	2
Precision System Science USA, Inc. Precision System Science USA, Inc. Medical SpecialtiesHealth Technology Part of Precision System Science Co., Ltd., Precision System Science USA, Inc. is a company that provides user-friendly technology for DNA extraction. The company is based in Pleasanton, CA. The company offers MagDEA® Dx LV Prefilled reagents cartridges for consistent and uniform magnetic bead-based nucleic acid extractions for large, 1 to 5 mL, sample volumes. Akihiro Furukawa has been the CEO of the company since 2017.	Health Technology
Universal Bio Research Co., Ltd.